Kostiantyn V. Kopchak
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Kostiantyn V. Kopchak has a total of 210 co-authors. Here are the top co-authors by number of shared publications:
- Андрій Володимирович Копчак
Bogomolets National Medical University
21 shared publications - Ihor Vasylovych Khomiak
Національний інститут хірургії та трансплантології імені О. О. Шалімова НАМН України, м. Київ
12 shared publications - Oleksandr Vasylovych Duvalko
Shalimov National Institute of Surgery and Transplantology, Kyiv
9 shared publications A V Duvalko
7 shared publicationsS V Andronik
7 shared publicationsIa V Romaniv
6 shared publications
Latest Publications
- Open Access
- 13 August 2026
- Published by State Institution of Science "Center of Innovative Healthcare Technologies" State Administrative Department in Clinical and Preventive Medicine
- No. 5,p. 14-19
IMPACT OF DISTAL PANCREATECTOMY ON LENGTH OF HOSPITAL STAY AFTER MULTIVISCERAL RESECTION FOR RETROPERITONEAL SARCOMA
Introduction. Retroperitoneal sarcomas often require extensive en bloc multivisceral resection to achieve macroscopically complete tumor removal. Distal pancreatectomy may be necessary, but its specific impact on early postoperative recovery remains difficult to distinguish from the overall complexity of multivisceral surgery.Aim. This study aimed to evaluate whether distal pancreatectomy is associated with prolonged hospital and intensive care unit stay after multivisceral resection for retroperitoneal sarcoma.Materials and methods. This retrospective cohort study was based on a prospectively maintained database and included patients with histologically confirmed retroperitoneal sarcoma who underwent multivisceral resection between 2016 and 2024. Multivisceral resection was defined as partial or complete resection of three or more organs or anatomical structures. Patients were divided into two groups according to whether distal pancreatectomy was performed. The primary outcome was postoperative length of hospital stay (LOS), and the secondary outcome was the duration of intensive care unit (ICU) stay. Between-group comparisons were performed using the Mann–Whitney U test.Results. The final analysis included 71 patients: 24 in the distal pancreatectomy group and 47 in the non-distal pancreatectomy group. Baseline demographic, clinical, tumor-related, and operative characteristics were comparable between the groups. Median postoperative LOS was significantly longer in the distal pancreatectomy group than in the non-distal pancreatectomy group: 19 days (IQR 13-31) versus 12 days (IQR 9-18), respectively (p = 0.002). Median ICU stay was also significantly longer in the distal pancreatectomy group: 19 hours (IQR 17-66) versus 18 hours (IQR 16-21), respectively (p = 0.031), mainly reflecting a wider upper interquartile range in patients undergoing distal pancreatectomy.Conclusions. Distal pancreatectomy during multivisceral resection for retroperitoneal sarcoma was associated with significantly prolonged postoperative hospital stay and a more variable ICU course. These findings suggest that distal pancreatectomy contributes to an increased early postoperative burden and should be considered during surgical planning, patient counseling, and perioperative resource allocation.
- 13 August 2026
- Published by State Institution of Science "Center of Innovative Healthcare Technologies" State Administrative Department in Clinical and Preventive Medicine
- No. 5,p. 14-19
Open AccessIMPACT OF DISTAL PANCREATECTOMY ON LENGTH OF HOSPITAL STAY AFTER MULTIVISCERAL RESECTION FOR RETROPERITONEAL SARCOMA
Introduction. Retroperitoneal sarcomas often require extensive en bloc multivisceral resection to achieve macroscopically complete tumor removal. Distal pancreatectomy may be necessary, but its specific impact on early postoperative recovery remains difficult to distinguish from the overall complexity of multivisceral surgery.Aim. This study aimed to evaluate whether distal pancreatectomy is associated with prolonged hospital and intensive care unit stay after multivisceral resection for retroperitoneal sarcoma.Materials and methods. This retrospective cohort study was based on a prospectively maintained database and included patients with histologically confirmed retroperitoneal sarcoma who underwent multivisceral resection between 2016 and 2024. Multivisceral resection was defined as partial or complete resection of three or more organs or anatomical structures. Patients were divided into two groups according to whether distal pancreatectomy was performed. The primary outcome was postoperative length of hospital stay (LOS), and the secondary outcome was the duration of intensive care unit (ICU) stay. Between-group comparisons were performed using the Mann–Whitney U test.Results. The final analysis included 71 patients: 24 in the distal pancreatectomy group and 47 in the non-distal pancreatectomy group. Baseline demographic, clinical, tumor-related, and operative characteristics were comparable between the groups. Median postoperative LOS was significantly longer in the distal pancreatectomy group than in the non-distal pancreatectomy group: 19 days (IQR 13-31) versus 12 days (IQR 9-18), respectively (p = 0.002). Median ICU stay was also significantly longer in the distal pancreatectomy group: 19 hours (IQR 17-66) versus 18 hours (IQR 16-21), respectively (p = 0.031), mainly reflecting a wider upper interquartile range in patients undergoing distal pancreatectomy.Conclusions. Distal pancreatectomy during multivisceral resection for retroperitoneal sarcoma was associated with significantly prolonged postoperative hospital stay and a more variable ICU course. These findings suggest that distal pancreatectomy contributes to an increased early postoperative burden and should be considered during surgical planning, patient counseling, and perioperative resource allocation.
- Open Access
- 31 March 2025
- Published by Publishing Company VIT-A-POL in General Surgery
- No. 1,p. 8-14
Evaluation of different methods of endoscopic papillectomy for adenomas of the major duodenal papilla
Objective – to assess the outcomes of endoscopic papillectomy (EP) using standard techniques, as well as to develop and implement novel surgical intervention approaches. Materials and methods. Between 2021 and 2024, the Department of Interventional Endoscopy at the National Cancer Institute performed EP for adenoma of the major duodenal papilla (MDP) on 19 patients, 10 women (52.63%) and 9 men (47.37%), aged 24 to 78 years, with a mean age of 45.6 years. We observed clinical signs of biliary obstruction and cholangitis in the majority of cases (2 (63.15%)). Results. 10 patients (52.63%) with tumours <1.0 cm underwent the standard procedure of en‑bloc loop resection (Group 1). To prevent intraoperative and postoperative complications, we developed and implemented a two‑stage EP procedure in 6 (31.57%) cases (Group 2). In 3 (15.78%) patients with tumours ranging from 5.0 to 8.0 cm, the piecemeal approach was used to remove all fragments from the area of the neoplasm that reached into the intestinal lumen (Group 3). After a three‑month follow‑up, 2 patients (10.5%) from Group 3 had a recurrence of an adenoma of the MDP. Both cases required loop diathermy excision for recurrent neoplasms and stent removal. Routine tests at 3 and 6 months revealed no evidence of disease progression. Conclusions. The topographic and anatomical characteristics of the MDP area determine the complexity of surgical interventions for patients with neoplasms. The novel EP approach minimizes the risks associated with both early and late postoperative complications. The outcomes achieved by employing EP in the treatment of patients with MDP adenomas support its recommendation as the primary approach at specialized centers.
- 31 March 2025
- Published by Publishing Company VIT-A-POL in General Surgery
- No. 1,p. 8-14
Open AccessEvaluation of different methods of endoscopic papillectomy for adenomas of the major duodenal papilla
Objective – to assess the outcomes of endoscopic papillectomy (EP) using standard techniques, as well as to develop and implement novel surgical intervention approaches. Materials and methods. Between 2021 and 2024, the Department of Interventional Endoscopy at the National Cancer Institute performed EP for adenoma of the major duodenal papilla (MDP) on 19 patients, 10 women (52.63%) and 9 men (47.37%), aged 24 to 78 years, with a mean age of 45.6 years. We observed clinical signs of biliary obstruction and cholangitis in the majority of cases (2 (63.15%)). Results. 10 patients (52.63%) with tumours <1.0 cm underwent the standard procedure of en‑bloc loop resection (Group 1). To prevent intraoperative and postoperative complications, we developed and implemented a two‑stage EP procedure in 6 (31.57%) cases (Group 2). In 3 (15.78%) patients with tumours ranging from 5.0 to 8.0 cm, the piecemeal approach was used to remove all fragments from the area of the neoplasm that reached into the intestinal lumen (Group 3). After a three‑month follow‑up, 2 patients (10.5%) from Group 3 had a recurrence of an adenoma of the MDP. Both cases required loop diathermy excision for recurrent neoplasms and stent removal. Routine tests at 3 and 6 months revealed no evidence of disease progression. Conclusions. The topographic and anatomical characteristics of the MDP area determine the complexity of surgical interventions for patients with neoplasms. The novel EP approach minimizes the risks associated with both early and late postoperative complications. The outcomes achieved by employing EP in the treatment of patients with MDP adenomas support its recommendation as the primary approach at specialized centers.
- Open Access
- 28 March 2025
- Published by Group of Companies Med Expert, LLC in Paediatric Surgery. Ukraine
- No. 1(86),p. 53-58
Pancreaticoduodenal resection with venous resection: experience of a high-profile center in Ukraine
Aim - to evaluate the feasibility and safety of venous resections (VR) during pancreatoduodenectomy (PD) in patients with malignant tumors of the periampullary region. Materials and methods. A retrospective cohort study was conducted, including 111 patients who underwent PD for malignant tumors of the periampullary region between 2018 and 2023. Patients were divided into two groups: with and without VR. Statistical analysis was performed to compare mean values and assess postoperative complications using the Clavien-Dindo classification. Results. Mean blood loss, operative time, rates of complications, delayed gastric emptying, postoperative pancreatic fistula, hospital and 30-day mortality did not differ significantly between the groups. Median overall survival was 22 months in the VR group and 37 months in the non-VR group; the 5-year survival rates were 22.2% and 35.9%, respectively. Conclusions. PD with VR is a safe and feasible procedure for patients with tumor invasion of major veins. The inclusion of VR does not significantly increase risks or worsen postoperative outcomes. The research was carried out in accordance with the principles of the Helsinki Declaration. The study protocol was approved by the Local Ethics Committee for all participants. The informed consent of the patients was obtained for the study. The authors declare no conflict of interest.
- 28 March 2025
- Published by Group of Companies Med Expert, LLC in Paediatric Surgery. Ukraine
- No. 1(86),p. 53-58
Open AccessPancreaticoduodenal resection with venous resection: experience of a high-profile center in Ukraine
Aim - to evaluate the feasibility and safety of venous resections (VR) during pancreatoduodenectomy (PD) in patients with malignant tumors of the periampullary region. Materials and methods. A retrospective cohort study was conducted, including 111 patients who underwent PD for malignant tumors of the periampullary region between 2018 and 2023. Patients were divided into two groups: with and without VR. Statistical analysis was performed to compare mean values and assess postoperative complications using the Clavien-Dindo classification. Results. Mean blood loss, operative time, rates of complications, delayed gastric emptying, postoperative pancreatic fistula, hospital and 30-day mortality did not differ significantly between the groups. Median overall survival was 22 months in the VR group and 37 months in the non-VR group; the 5-year survival rates were 22.2% and 35.9%, respectively. Conclusions. PD with VR is a safe and feasible procedure for patients with tumor invasion of major veins. The inclusion of VR does not significantly increase risks or worsen postoperative outcomes. The research was carried out in accordance with the principles of the Helsinki Declaration. The study protocol was approved by the Local Ethics Committee for all participants. The informed consent of the patients was obtained for the study. The authors declare no conflict of interest.
- 8 June 2023
- Published by The Korean Association of Hepato-Biliary-Pancreatic Surgery in Annals of Hepato-Biliary-Pancreatic Surgery
- Vol. 27 (1) , S284
Simultaneous laparoscopic resection of primary colorectal cancer and synchronus liver metastases: Initial experience of single institute
Oleksandr KVASIVKA, Vitalii ZVIRYCH, Anatoliy SHUDRAK, Andiy BEZNOSENKO, Kostiantyn KOPCHAK*. Ann Hepatobiliary Pancreat Surg 2023;27:S284. https://doi.org/10.14701/ahbps.2023S1.EP-17
- 8 June 2023
- Published by The Korean Association of Hepato-Biliary-Pancreatic Surgery in Annals of Hepato-Biliary-Pancreatic Surgery
- Vol. 27 (1) , S284
Simultaneous laparoscopic resection of primary colorectal cancer and synchronus liver metastases: Initial experience of single institute
Oleksandr KVASIVKA, Vitalii ZVIRYCH, Anatoliy SHUDRAK, Andiy BEZNOSENKO, Kostiantyn KOPCHAK*. Ann Hepatobiliary Pancreat Surg 2023;27:S284. https://doi.org/10.14701/ahbps.2023S1.EP-17
- 8 June 2023
- Published by The Korean Association of Hepato-Biliary-Pancreatic Surgery in Annals of Hepato-Biliary-Pancreatic Surgery
- Vol. 27 (1) , S403
Hybrid laparoscopic pancreaticoduodenectomy: Ukrainian single center experience
Oleksandr KVASIVKA, Sergiy ZEMSKOV, Kostiantyn KOPCHAK*. Ann Hepatobiliary Pancreat Surg 2023;27:S403. https://doi.org/10.14701/ahbps.2023S1.EP-137
- 8 June 2023
- Published by The Korean Association of Hepato-Biliary-Pancreatic Surgery in Annals of Hepato-Biliary-Pancreatic Surgery
- Vol. 27 (1) , S403
Hybrid laparoscopic pancreaticoduodenectomy: Ukrainian single center experience
Oleksandr KVASIVKA, Sergiy ZEMSKOV, Kostiantyn KOPCHAK*. Ann Hepatobiliary Pancreat Surg 2023;27:S403. https://doi.org/10.14701/ahbps.2023S1.EP-137
- Open Access
- 13 April 2023
- Published by Wolters Kluwer Health in Annals of Medicine & Surgery
- Vol. 85 (5) , 1413-1419
Twenty-year experience in liver surgery in metastatic colorectal patients: a case series study in Ukraine
Background: For the last three decades, the world surgical community successfully adopted different surgical strategies for colorectal cancer (CRC) patients with liver metastases (LM), however, we are still seeing the evolution of treatment guidelines. The purpose of the study was to analyze a 20-year evolution of CRC patients with LM being treated in a specialized state Ukrainian oncological center. Materials and methods: The retrospective analysis of 1118 CRC patient cases using prospectively collected patient data from the National Cancer Institute registry. The time ranges between 2000–2010 and 2011–2022 and the LM manifestation – metachronous (M0)/synchronous (M1) were the two main grouping criteria. Results: The overall survival 5-year survival of patients who had surgery between 2000–2011 and 2012–2022 was 51.3 and 58.2% (P=0.61) for the M0 cohort and 22.6 and 34.7% at M1 (P=0.002), respectively. The results of the multivariate analysis in 1118 cases revealed that liver re-resection and regional lymph node dissection ≥D2 were associated with better overall survival [hazard ratio (95% CI)=0.76 (0.58–0.99) P=0.04] in the M0 cohort and receiving at least 15 courses of chemotherapy had better recurrence-free survival rates [hazard ratio (95% CI)=0.97 (0.95–0.99), P=0.03] for both M0 and M1. Conclusions: It was shown the improvement of the oncological prognosis for CRC patients with synchronous LM who were treated after 2012. The adaptation of world experience algorithms and the surgical strategy evolution have become the root cause of the above.
- 13 April 2023
- Published by Wolters Kluwer Health in Annals of Medicine & Surgery
- Vol. 85 (5) , 1413-1419
Open AccessTwenty-year experience in liver surgery in metastatic colorectal patients: a case series study in Ukraine
Background: For the last three decades, the world surgical community successfully adopted different surgical strategies for colorectal cancer (CRC) patients with liver metastases (LM), however, we are still seeing the evolution of treatment guidelines. The purpose of the study was to analyze a 20-year evolution of CRC patients with LM being treated in a specialized state Ukrainian oncological center. Materials and methods: The retrospective analysis of 1118 CRC patient cases using prospectively collected patient data from the National Cancer Institute registry. The time ranges between 2000–2010 and 2011–2022 and the LM manifestation – metachronous (M0)/synchronous (M1) were the two main grouping criteria. Results: The overall survival 5-year survival of patients who had surgery between 2000–2011 and 2012–2022 was 51.3 and 58.2% (P=0.61) for the M0 cohort and 22.6 and 34.7% at M1 (P=0.002), respectively. The results of the multivariate analysis in 1118 cases revealed that liver re-resection and regional lymph node dissection ≥D2 were associated with better overall survival [hazard ratio (95% CI)=0.76 (0.58–0.99) P=0.04] in the M0 cohort and receiving at least 15 courses of chemotherapy had better recurrence-free survival rates [hazard ratio (95% CI)=0.97 (0.95–0.99), P=0.03] for both M0 and M1. Conclusions: It was shown the improvement of the oncological prognosis for CRC patients with synchronous LM who were treated after 2012. The adaptation of world experience algorithms and the surgical strategy evolution have become the root cause of the above.
- 30 April 2022
- Published by Publishing Company VIT-A-POL in General Surgery
- No. 1,p. 61-65
Primary pancreatic lymphoma: a rare tumour that mimics pancreatic carcinoma. Clinical case
Primary pancreatic lymphomas are extremely rare. Clinically, primary pancreatic lymphomas usually present with symptoms of pancreatic carcinoma. A localized and well‑circumscribed tumour that replaces most of the pancreatic gland and compression of the blood vessels are radiological features of lymphoma, which are similar to pancreatic adenocarcinoma. Many patients are diagnosed with lymphoma after radical resection. It’s a challenging clinical task for physicians, radiologists, and pathologists. We report a case of primary pancreatic lymphoma that was confirmed by surgical resection. A 60‑year‑old woman came to the clinic with non‑specific upper abdominal pain that lasted 8 weeks. Computed tomography (CT) scan showed a mass in the body of the pancreas, involving the superior mesenteric artery and the celiac trunk, and regional lymphadenopathy. Endoscopic ultrasound‑guided fine needle aspiration of the pancreatic mass was performed. A morphological pattern indicated ductal carcinoma. The tumour board determined the treatment plan (chemotherapy) for the patient. The patient underwent 3 courses of GEMCAP chemotherapy in our hospital. A follow‑up radiological exam showed no improvement. The chemotherapy regimen was changed to FOLFIRINOX. The patient underwent 6 courses of the FOLFIRINOX regimen. A follow‑up magnetic resonance imaging of the pancreas showed tumour regression by more than 90 % in comparison with the previous study. The patient underwent distal pancreatosplenectomy with standard lymph node dissection. Postoperative period was uncomplicated. These pathological results confirm the diagnosis of diffuse B‑cell lymphoma. Conclusions. This case shows that lack of tissue can make histological examination of FNA specimens challenging and mistakes can happen due to rare occurrence of primary pancreatic lymphomas.
- 30 April 2022
- Published by Publishing Company VIT-A-POL in General Surgery
- No. 1,p. 61-65
Primary pancreatic lymphoma: a rare tumour that mimics pancreatic carcinoma. Clinical case
Primary pancreatic lymphomas are extremely rare. Clinically, primary pancreatic lymphomas usually present with symptoms of pancreatic carcinoma. A localized and well‑circumscribed tumour that replaces most of the pancreatic gland and compression of the blood vessels are radiological features of lymphoma, which are similar to pancreatic adenocarcinoma. Many patients are diagnosed with lymphoma after radical resection. It’s a challenging clinical task for physicians, radiologists, and pathologists. We report a case of primary pancreatic lymphoma that was confirmed by surgical resection. A 60‑year‑old woman came to the clinic with non‑specific upper abdominal pain that lasted 8 weeks. Computed tomography (CT) scan showed a mass in the body of the pancreas, involving the superior mesenteric artery and the celiac trunk, and regional lymphadenopathy. Endoscopic ultrasound‑guided fine needle aspiration of the pancreatic mass was performed. A morphological pattern indicated ductal carcinoma. The tumour board determined the treatment plan (chemotherapy) for the patient. The patient underwent 3 courses of GEMCAP chemotherapy in our hospital. A follow‑up radiological exam showed no improvement. The chemotherapy regimen was changed to FOLFIRINOX. The patient underwent 6 courses of the FOLFIRINOX regimen. A follow‑up magnetic resonance imaging of the pancreas showed tumour regression by more than 90 % in comparison with the previous study. The patient underwent distal pancreatosplenectomy with standard lymph node dissection. Postoperative period was uncomplicated. These pathological results confirm the diagnosis of diffuse B‑cell lymphoma. Conclusions. This case shows that lack of tissue can make histological examination of FNA specimens challenging and mistakes can happen due to rare occurrence of primary pancreatic lymphomas.
- 1 November 2021
- Published by Edizioni Minerva Medica in Minerva Surgery
- Vol. 76 (5) , 429-435
Methods of preventing the occurrence of postoperative complications in patients with pancreaticoduodenectomy
Article: Methods of preventing the occurrence of postoperative complications in patients with pancreaticoduodenectomy - Minerva Surgery 2021 May 04 - Minerva Medica - Journals
- 1 November 2021
- Published by Edizioni Minerva Medica in Minerva Surgery
- Vol. 76 (5) , 429-435
Methods of preventing the occurrence of postoperative complications in patients with pancreaticoduodenectomy
Article: Methods of preventing the occurrence of postoperative complications in patients with pancreaticoduodenectomy - Minerva Surgery 2021 May 04 - Minerva Medica - Journals
- Open Access
- 29 December 2020
- Published by Publishing Office TRILIST in Reproductive Endocrinology
- No. 56,p. 35-37
External genital tumors in women: role of differentiation, localization and histological types for predicting long-term survival value
Purpose of the study was to investigate the role of the tumor degree, localization and histological type of tumor at the level of long-term survival by 25-year retrospective observation in women with external genitalia cancer. Materials and methods. 557 medical records of patients treated in National Cancer Institute have been analyzed during the period of 1993–2018 years. Impact of the differentiation degree, localization and histological type on the long-term survival value has been evaluated. Results. It has been proved that the long-term survival value decreased by 27.3% during transition from high (G3) to intermediate (G2) tumor grade, by 10.8% during transition from intermediate (G2) to low (G1) tumor grade. The overall level of 25-year survival retrospectively constituted 45.0% with G3 tumor grade, 31.0% with G2, and 26.0% with G1 tumor grade (p Conclusion. The highest rates of cancer mortality are verified in non-differentiated forms of tumor (100.0%) and for sarcoma (63.6%) depending on the morphological form of primary tumor. Mortality rate was more than 50.0% for all forms of squamous cell cancer. Carcinoma and adenocarcinoma with a level of mortality by 20.6 % and 21.4% respectively were more favorable compared to the other morphological forms.
- 29 December 2020
- Published by Publishing Office TRILIST in Reproductive Endocrinology
- No. 56,p. 35-37
Open AccessExternal genital tumors in women: role of differentiation, localization and histological types for predicting long-term survival value
Purpose of the study was to investigate the role of the tumor degree, localization and histological type of tumor at the level of long-term survival by 25-year retrospective observation in women with external genitalia cancer. Materials and methods. 557 medical records of patients treated in National Cancer Institute have been analyzed during the period of 1993–2018 years. Impact of the differentiation degree, localization and histological type on the long-term survival value has been evaluated. Results. It has been proved that the long-term survival value decreased by 27.3% during transition from high (G3) to intermediate (G2) tumor grade, by 10.8% during transition from intermediate (G2) to low (G1) tumor grade. The overall level of 25-year survival retrospectively constituted 45.0% with G3 tumor grade, 31.0% with G2, and 26.0% with G1 tumor grade (p Conclusion. The highest rates of cancer mortality are verified in non-differentiated forms of tumor (100.0%) and for sarcoma (63.6%) depending on the morphological form of primary tumor. Mortality rate was more than 50.0% for all forms of squamous cell cancer. Carcinoma and adenocarcinoma with a level of mortality by 20.6 % and 21.4% respectively were more favorable compared to the other morphological forms.
- Open Access
- 16 March 2020
- Published by Springer Nature in Indian Journal of Surgical Oncology
- Vol. 11 (2) , 263-267
Establishing of Peritoneal Surface Malignancy Treatment Program: Background in Ukraine, Patient Selection, Staff Schedule, Perioperative Outcomes of First 28 Patients
A combination of cytoreductive intervention with the intrahepatic hyperthermic chemotherapy is a well-established treatment of peritoneal carcinomatosis. There are many challenges in establishing a new peritoneal surface malignancy program in a low-income country regarding perioperative safety and resource allocation. We analyzed the retrospective database to determine the immediate surgical outcomes of the first 28 patients with peritoneal carcinomatosis and the impact of the program on allocation of general hospital and human resources. During the preparatory stage, web conferences with international experts established the goals and general requirements of the program, formalized in a written document; and a peritoneal surface malignancy multidisciplinary team was established. The team created the patient selection criteria, perioperative management checklists, and suggested material and staff requirements for surgical and anesthesia services. Twenty-nine cytoreduction were carried out, of which 18 were followed by HIPEC. The average operative time was 6.2 h. The median blood loss was 350 mL, which did not result in additional blood transfusion requirements for the blood bank. No additional nursing and supportive staff were provided for the ICU and the surgical unit. The average postoperative stay was 8.7 days. One patient died with 30-day mortality rate of 3%. Ten patients (34.5%) developed postoperative complications, of which 6 (20.6%) had grade III and higher Clavien-Dindo complications. Establishing a peritoneal surface malignancy program is possible via staged planning, liberal use of international mentors, and thoughtful resource allocation. This new program did not result in a significant redistribution of resources among other service lines of cancer care within the same institution.
- 16 March 2020
- Published by Springer Nature in Indian Journal of Surgical Oncology
- Vol. 11 (2) , 263-267
Open AccessEstablishing of Peritoneal Surface Malignancy Treatment Program: Background in Ukraine, Patient Selection, Staff Schedule, Perioperative Outcomes of First 28 Patients
A combination of cytoreductive intervention with the intrahepatic hyperthermic chemotherapy is a well-established treatment of peritoneal carcinomatosis. There are many challenges in establishing a new peritoneal surface malignancy program in a low-income country regarding perioperative safety and resource allocation. We analyzed the retrospective database to determine the immediate surgical outcomes of the first 28 patients with peritoneal carcinomatosis and the impact of the program on allocation of general hospital and human resources. During the preparatory stage, web conferences with international experts established the goals and general requirements of the program, formalized in a written document; and a peritoneal surface malignancy multidisciplinary team was established. The team created the patient selection criteria, perioperative management checklists, and suggested material and staff requirements for surgical and anesthesia services. Twenty-nine cytoreduction were carried out, of which 18 were followed by HIPEC. The average operative time was 6.2 h. The median blood loss was 350 mL, which did not result in additional blood transfusion requirements for the blood bank. No additional nursing and supportive staff were provided for the ICU and the surgical unit. The average postoperative stay was 8.7 days. One patient died with 30-day mortality rate of 3%. Ten patients (34.5%) developed postoperative complications, of which 6 (20.6%) had grade III and higher Clavien-Dindo complications. Establishing a peritoneal surface malignancy program is possible via staged planning, liberal use of international mentors, and thoughtful resource allocation. This new program did not result in a significant redistribution of resources among other service lines of cancer care within the same institution.